Cardiol Therapeutics (CRDL) News Today → AI Bubble Now at Critical Mass (From Porter & Company) (Ad) Free CRDL Stock Alerts C$2.43 -0.07 (-2.80%) (As of 01:45 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCardiol Therapeutics (TSE:CRDL) Stock Price Down 1%americanbankingnews.com - March 19 at 1:42 AMCardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditisfinance.yahoo.com - February 21 at 8:53 AMClosing Bell: Cardiol Therapeutics Inc Purchase WT down on Monday (CRDL-WT-A)theglobeandmail.com - February 9 at 8:03 AMIs Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?finance.yahoo.com - February 2 at 12:14 PMCardiol Therapeutics Inc Class Amorningstar.com - January 30 at 8:57 AMCardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilotfinance.yahoo.com - December 5 at 9:44 AMCardiol Therapeutics reaches new milestone in Phase II study for recurrent pericarditisproactiveinvestors.com - November 1 at 9:27 AMCardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditisfinance.yahoo.com - November 1 at 9:27 AMCardiol Therapeutics Inc.: Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirementfinanznachrichten.de - October 23 at 1:08 PMCardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseasesfinance.yahoo.com - October 13 at 12:51 PMCardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseasesfinance.yahoo.com - October 13 at 12:51 PMCardiol Therapeutics releases positive study results of...Cardiol Therapeutics releases positive study results of...proactiveinvestors.com - October 11 at 1:00 PMCBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effectsbenzinga.com - October 10 at 3:47 PMCardiol Therapeutics Inc.: Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conferencefinanznachrichten.de - September 28 at 1:00 PMCardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conferencefinance.yahoo.com - September 26 at 8:30 AMCardiol Therapeutics on track to complete enrollment for acute myocarditis trial six months ahead of scheduleproactiveinvestors.com - September 19 at 12:04 PMCardiol Therapeutics Inc. (CRDL) Upgraded to Buy: Here's What You Should Knowmsn.com - August 16 at 1:30 PMCRDL.TO - Cardiol Therapeutics Inc.finance.yahoo.com - June 6 at 3:08 PMCardiol Therapeutics (CRDL) Earnings Dates & Reportsinvesting.com - May 19 at 9:03 AMClosing Bell: Cardiol Therapeutics Inc down on Monday (CRDL)theglobeandmail.com - May 9 at 12:58 AMClosing Bell: Cardiol Therapeutics Inc up on Friday (CRDL)theglobeandmail.com - April 21 at 7:49 PMClosing Bell: Cardiol Therapeutics Inc up on Tuesday (CRDL)theglobeandmail.com - April 12 at 1:30 AMClosing Bell: Cardiol Therapeutics Inc flat on Thursday (CRDL)theglobeandmail.com - April 8 at 6:07 AMClosing Bell: Cardiol Therapeutics Inc down on Wednesday (CRDL)theglobeandmail.com - April 6 at 4:25 PMCardiol Therapeutics Inc. (CRDL.TO)uk.finance.yahoo.com - April 1 at 11:50 PMCardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failurefinance.yahoo.com - March 7 at 8:35 AMCRDL Cardiol Therapeutics Inc.seekingalpha.com - February 17 at 8:00 AMCardiol Therapeutics enrols first patient in Phase 2 study of CardiolRx for Recurrent Pericarditisproactiveinvestors.com - January 17 at 5:30 PMCardiol Therapeutics Inc.: Cardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx for the Treatment of Recurrent Pericarditisfinanznachrichten.de - December 12 at 8:25 AMCardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx(TM) for the Treatment of Recurrent Pericarditisfinance.yahoo.com - December 12 at 8:25 AMCardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirementfinance.yahoo.com - November 15 at 2:11 AMCardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx(TM) in a Model of Acute Pericarditisfinance.yahoo.com - November 7 at 8:23 AMCardiol Therapeutics to prioritize its Phase II clinical programs focused on developing CardiolRx for two underserved diseases affecting the heartproactiveinvestors.com - October 25 at 11:48 AMCardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseasesfinance.yahoo.com - October 25 at 6:47 AMCardiol Therapeutics unveils new preclinical study results providing evidence of cardioprotective properties of CardiolRxproactiveinvestors.com - October 3 at 1:33 PMCardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx(TM) Inhibits and also Promotes Reversal of Mechanisms Leading to Cardiac Fibrosisfinance.yahoo.com - October 3 at 8:32 AMCardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of Americafinance.yahoo.com - September 28 at 9:49 AMCardiol Therapeutics says first patient enrolled in acute myocarditis trial of its oral cannabinoid formulation CardiolRxproactiveinvestors.com - August 3 at 3:01 PMCardiol Therapeutics hits major milestone with first patient enrolled in Phase 2 trial of CardiolRXproactiveinvestors.com - August 3 at 3:01 PMFinancialnewsmedia.com: Air Pollution is a Global Heart and Lung Health Concernfinanznachrichten.de - July 18 at 1:48 PMCardiol Therapeutics Reports Results of 2022 Annual General Meetingfinance.yahoo.com - June 29 at 6:04 PMCardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 P.M. EDTfinance.yahoo.com - June 27 at 5:46 PMCardiol Therapeutics is conducting clinical trials of its pure cannabidiol formulation, CardiolRx, to treat inflammatory heart diseaseproactiveinvestors.com - June 16 at 12:38 PMFinancialnewsmedia.com: Breakthroughs In Treating Killer Diseases Could Lengthen Lifefinanznachrichten.de - June 7 at 11:53 AMBreakthroughs In Treating Killer Diseases Could Lengthen Lifebenzinga.com - June 7 at 11:53 AMMarket Movers. Today’s Top Stock Picks For New & Trending Opportunitiesfinance.yahoo.com - May 27 at 2:32 PMCardiol wins FDA nod to study oral cannabidiol drug in recurrent pericarditisseekingalpha.com - May 17 at 8:35 AMFinancialNewsMedia.com: Heart Failure Treatment Offers Hope to Diabeticsfinanznachrichten.de - May 11 at 9:35 AMInterview: Cardiol Therapeutics' CEO on the Company's Market Debut and Futureinvesting.com - March 30 at 12:04 PMCardiol Therapeutics looks ahead to busy 2022 as it advances new treatment options for cardiovascular diseaseproactiveinvestors.com - March 24 at 12:26 PM Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address AI Bubble Now at Critical Mass (Ad)Washington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom. Simply click here now to read The Big AI Die-Up. CRDL Media Mentions By Week CRDL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRDL News Sentiment▼0.000.60▲Average Medical News Sentiment CRDL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRDL Articles This Week▼00▲CRDL Articles Average Week Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HLS Therapeutics News BioSyent News Cipher Pharmaceuticals News Charlotte's Web News Aurora Cannabis News Organigram News Canopy Growth News Spectral Medical News Oncolytics Biotech News Medicenna Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CRDL) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingFed launches fourth dollar overhaulStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.